E Grace

1.0k total citations
27 papers, 792 citations indexed

About

E Grace is a scholar working on Rheumatology, Pharmacology and Surgery. According to data from OpenAlex, E Grace has authored 27 papers receiving a total of 792 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Rheumatology, 6 papers in Pharmacology and 5 papers in Surgery. Recurrent topics in E Grace's work include Rheumatoid Arthritis Research and Therapies (9 papers), Pain Mechanisms and Treatments (3 papers) and Pharmacogenetics and Drug Metabolism (3 papers). E Grace is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (9 papers), Pain Mechanisms and Treatments (3 papers) and Pharmacogenetics and Drug Metabolism (3 papers). E Grace collaborates with scholars based in Canada, Australia and Japan. E Grace's co-authors include Peter Tugwell, W. Watson Buchanan, Claire Bombardier, Barbara Hanna, Charlie H. Goldsmith, Anne M. Rentz, Nancy Kline Leidy, Carlota Saldanha, W. Watson Buchanan and Nicholas Bellamy and has published in prestigious journals such as Gastroenterology, The American Journal of Medicine and Annals of the Rheumatic Diseases.

In The Last Decade

E Grace

26 papers receiving 722 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
E Grace Canada 12 322 150 137 125 122 27 792
R Neame United Kingdom 10 364 1.1× 112 0.7× 50 0.4× 51 0.4× 51 0.4× 18 865
Harry Houben Netherlands 14 561 1.7× 129 0.9× 203 1.5× 160 1.3× 231 1.9× 16 1.1k
Rachel Halpern United States 15 100 0.3× 147 1.0× 149 1.1× 79 0.6× 76 0.6× 42 822
Timothy W. Victor United States 12 210 0.7× 93 0.6× 110 0.8× 34 0.3× 170 1.4× 16 750
Julie Birt United States 22 455 1.4× 92 0.6× 214 1.6× 260 2.1× 76 0.6× 61 1.2k
Raye H. Brooks United States 17 1.2k 3.6× 115 0.8× 97 0.7× 390 3.1× 226 1.9× 25 1.5k
Sofia Pedro United States 16 488 1.5× 88 0.6× 119 0.9× 141 1.1× 43 0.4× 38 954
T. Michelle Brown United States 17 84 0.3× 69 0.5× 107 0.8× 163 1.3× 49 0.4× 46 862
Silvia Díaz‐Cerezo Spain 15 112 0.3× 82 0.5× 88 0.6× 41 0.3× 137 1.1× 78 810
David H. Adams United States 20 177 0.5× 289 1.9× 287 2.1× 103 0.8× 105 0.9× 36 1.3k

Countries citing papers authored by E Grace

Since Specialization
Citations

This map shows the geographic impact of E Grace's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E Grace with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E Grace more than expected).

Fields of papers citing papers by E Grace

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E Grace. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E Grace. The network helps show where E Grace may publish in the future.

Co-authorship network of co-authors of E Grace

This figure shows the co-authorship network connecting the top 25 collaborators of E Grace. A scholar is included among the top collaborators of E Grace based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E Grace. E Grace is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chiba, Naoki, S. J. O. Veldhuyzen van Zanten, Sergio Escobedo, et al.. (2004). Economic evaluation of Helicobacter pylori eradication in the CADET‐Hp randomized controlled trial of H. pylori‐positive primary care patients with uninvestigated dyspepsia. Alimentary Pharmacology & Therapeutics. 19(3). 349–358. 29 indexed citations
2.
Grace, E, et al.. (2004). The clinical and economic impact of pneumococcal conjugate vaccine associated herd immunity in Canada. Journal of Medical Economics. 7(1-4). 85–92. 3 indexed citations
3.
Chiba, Naoki, et al.. (2001). The cost-effectiveness of a H. pylori test and treat approach in primary care uninvestigated dyspepsia patients. Gastroenterology. 120(5). A89–A89. 4 indexed citations
4.
Leidy, Nancy Kline, Anne M. Rentz, & E Grace. (1998). Evaluating Health‐Related Quality of Life Outcomes in Clinical Trials of Antiepileptic Drug Therapy. Epilepsia. 39(9). 965–977. 52 indexed citations
5.
Grace, E, E Lyrenäs, T. D. Bolin, et al.. (1998). Problems which address health related quality of life (HRQOL) in inflammatory bowel disease (IBD). Gastroenterology. 114. A1002–A1003. 1 indexed citations
6.
Tugwell, Peter, D Ludwin, Richard J. Roberts, et al.. (1997). Interaction between cyclosporin A and nonsteroidal antiinflammatory drugs.. PubMed. 24(6). 1122–5. 6 indexed citations
7.
Bensen, W., et al.. (1994). Combination therapy of cyclosporine with methotrexate and gold in rheumatoid arthritis (2 pilot studies).. PubMed. 21(11). 2034–8. 34 indexed citations
8.
Kean, Walter F., et al.. (1992). The Pharmacokinetics of Flurbiprofen in Younger and Elderly Patients with Rheumatoid Arthritis. The Journal of Clinical Pharmacology. 32(1). 41–48. 19 indexed citations
9.
Tugwell, Peter, Claire Bombardier, Mary Bell, et al.. (1991). Current quality-of-life research challenges in arthritis relevant to the issue of clinical significance. Controlled Clinical Trials. 12(4). S217–S225. 9 indexed citations
10.
Grace, E, et al.. (1988). 50-FOOT WALKING TIME: A CRITICAL ASSESSMENT OF AN OUTCOME MEASURE IN CLINICAL THERAPEUTIC TRIALS OF ANTIRHEUMATIC DRUGS. Lara D. Veeken. 27(5). 372–374. 44 indexed citations
11.
Kamath, Markad V., et al.. (1988). Computerized Cheirometer for Assessing Grip-Strength Indices and Classification of Rheumatoid Patients. Engineering in Medicine. 17(1). 17–22. 1 indexed citations
12.
Grace, E, Jack Rosenfeld, G.D. Sweeney, & W. Watson Buchanan. (1987). The pharmacokinetics of isoxicam in elderly patients with rheumatoid arthritis. Current Medical Research and Opinion. 10(9). 580–591. 4 indexed citations
13.
Rosenbloom, David, E Grace, Peter Brooks, et al.. (1987). Effects of aspirin, naloxone and placebo. Clinical Rheumatology. 6(4). 526–531.
14.
Tugwell, Peter, Claire Bombardier, Kathryn Bennett, et al.. (1987). Low dose cyclosporine in rheumatoid arthritis: a pilot study.. PubMed. 14(6). 1108–14. 27 indexed citations
15.
Grace, E, et al.. (1986). Trimipramine in rheumatoid arthritis: a randomized double-blind trial in relieving pain and joint tenderness. Current Medical Research and Opinion. 10(2). 89–93. 33 indexed citations
16.
Grace, E, et al.. (1986). Lowering of plasma isoxicam concentrations with acetylsalicylic acid.. PubMed. 13(6). 1119–21. 6 indexed citations
17.
Tugwell, Peter, et al.. (1985). Grading of tenderness as a source of interrater error in the Ritchie articular index.. PubMed. 12(4). 716–7. 62 indexed citations
18.
Grace, E, et al.. (1985). Controlled, double-blind, randomized trial of amitriptyline in relieving articular pain and tenderness in patients with rheumatoid arthritis. Current Medical Research and Opinion. 9(6). 426–429. 28 indexed citations
19.
Buchanan, W. Watson, et al.. (1984). Rheumatoid Hand Weakness Characterising Indices and Clinical Data Acquisition. Engineering in Medicine. 13(3). 115–120. 4 indexed citations
20.
Sills, J A, et al.. (1978). XXX syndrome associated with immunoglobulin deficiency and epilepsy. The Journal of Pediatrics. 93(3). 469–471. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026